Stocks
Cassava Sciences Inc Financial Statements (SAVA) |
||||||||||
| Cassava Sciences Incsmart-lab.ru | % | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 01.05.2023 | 03.08.2023 | 07.11.2023 | 28.02.2024 | 10.05.2024 | 10.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.000 | 0.000 | 0.000 | 2.35 | 0.000 | 2.35 | |||
| Operating Income, bln rub | -26.9 | -28.8 | -27.9 | -22.8 | -19.9 | -99.4 | ||||
| EBITDA, bln rub | ? | -26.5 | -28.8 | -27.9 | -22.4 | -19.6 | -98.7 | |||
| Net profit, bln rub | ? | -21.6 | -26.4 | -25.7 | -20.9 | 25.0 | -47.9 | |||
| OCF, bln rub | ? | -13.3 | -19.9 | -26.5 | -22.3 | -19.1 | -87.9 | |||
| CAPEX, bln rub | ? | 0.357 | 0.006 | 0.022 | 0.041 | 0.000 | 0.069 | |||
| FCF, bln rub | ? | -13.6 | -19.9 | -26.6 | -22.4 | -19.1 | -88.0 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 26.5 | 28.8 | 27.9 | 22.4 | 19.6 | 98.7 | ||||
| Cost of production, bln rub | 0.391 | 0.391 | 0.392 | 0.356 | 0.311 | 1.45 | ||||
| R&D, bln rub | 22.1 | 25.0 | 23.6 | 18.7 | 16.2 | 83.5 | ||||
| Interest expenses, bln rub | 2.63 | 0.000 | 0.000 | 2.63 | 0.000 | 2.63 | ||||
| Assets, bln rub | 218.1 | 197.2 | 172.5 | 151.7 | 155.7 | 155.7 | ||||
| Net Assets, bln rub | ? | 204.0 | 179.4 | 155.1 | 137.5 | 78.6 | 78.6 | |||
| Debt, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Cash, bln rub | 187.5 | 168.4 | 142.4 | 121.1 | 124.2 | 124.2 | ||||
| Net debt, bln rub | -187.5 | -168.4 | -142.4 | -121.1 | -124.2 | -124.2 | ||||
| Ordinary share price, rub | 24.1 | 24.5 | 16.6 | 22.5 | 20.3 | 25.8 | ||||
| Number of ordinary shares, mln | 41.7 | 41.8 | 42.0 | 42.2 | 43.0 | 43.0 | ||||
| Market cap, bln rub | 1 007 | 1 025 | 699 | 950 | 872 | 1 107 | ||||
| EV, bln rub | ? | 819 | 856 | 557 | 829 | 748 | 983 | |||
| Book value, bln rub | 204 | 179 | 155 | 137 | 78 | 78 | ||||
| EPS, rub | ? | -0.52 | -0.63 | -0.61 | -0.50 | 0.58 | -1.11 | |||
| FCF/share, rub | -0.33 | -0.48 | -0.63 | -0.53 | -0.44 | -2.05 | ||||
| BV/share, rub | 4.88 | 4.28 | 3.69 | 3.25 | 1.83 | 1.83 | ||||
| EBITDA margin, % | ? | -955.4% | -4 204% | |||||||
| Net margin, % | ? | -890.9% | -2 040% | |||||||
| FCF yield, % | ? | -6.94% | -7.54% | -11.6% | -8.68% | -10.1% | -7.94% | |||
| ROE, % | ? | -37.5% | -47.1% | -58.7% | -68.8% | -60.9% | -60.9% | |||
| ROA, % | ? | -35.1% | -42.8% | -52.7% | -62.4% | -30.8% | -30.8% | |||
| P/E | ? | -13.1 | -12.1 | -7.68 | -10.0 | -18.2 | -23.1 | |||
| P/FCF | -14.4 | -13.3 | -8.62 | -11.5 | -9.92 | -12.6 | ||||
| P/S | ? | 0.00 | 0.00 | 0.00 | 404.5 | 371.6 | 471.6 | |||
| P/BV | ? | 4.95 | 5.73 | 4.51 | 6.92 | 11.1 | 14.1 | |||
| EV/EBITDA | ? | -9.24 | -8.78 | -5.35 | -7.85 | -7.58 | -9.96 | |||
| Debt/EBITDA | 2.11 | 1.73 | 1.37 | 1.15 | 1.26 | 1.26 | ||||
| R&D/CAPEX, % | 6 196% | 416 150% | 107 286% | 45 685% | 121 067% | |||||
| CAPEX/Revenue, % | 1.75% | 2.94% | ||||||||
| Cassava Sciences Inc shareholders | ||||||||||
